Free Trial

Crinetics Pharmaceuticals (CRNX) SEC Filings & 10K Form

Crinetics Pharmaceuticals logo
$54.93 -0.44 (-0.79%)
(As of 09:51 AM ET)

Recent Crinetics Pharmaceuticals SEC Filings

DateFilerForm TypeView
12/16/2024
3:32 PM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
7:07 AM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
3:06 PM
Crinetics Pharmaceuticals (Subject)
Struthers Richard Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
3:30 PM
Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
6:55 PM
Crinetics Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:46 PM
Crinetics Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G/A
11/12/2024
1:26 PM
Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/08/2024
9:52 AM
Crinetics Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/04/2024
10:20 AM
Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/17/2024
11:47 AM
Crinetics Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/16/2024
3:08 PM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
4:13 PM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
3:35 PM
Crinetics Pharmaceuticals (Filer)
Form 424B5
10/08/2024
4:01 PM
Crinetics Pharmaceuticals (Filer)
Form 424B5
10/07/2024
6:55 AM
Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
4:01 PM
Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2024
3:23 PM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
3:06 PM
Crinetics Pharmaceuticals (Subject)
Wilson Marc (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:30 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
11:11 AM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
3:31 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
12:16 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
10:35 AM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/26/2024
3:38 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
3:04 PM
Crinetics Pharmaceuticals (Subject)
Wilson Marc (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2024
9:54 AM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
4:35 PM
Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:14 PM
Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
3:38 PM
Crinetics Pharmaceuticals (Subject)
Knight Jeff E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
3:28 PM
Crinetics Pharmaceuticals (Subject)
Wilson Marc (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
3:30 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
9:28 AM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
5:04 PM
Crinetics Pharmaceuticals (Issuer)
Hassard James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2024
3:30 PM
Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2024
3:10 PM
Crinetics Pharmaceuticals (Subject)
Hassard James (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2024
12:07 PM
Crinetics Pharmaceuticals (Subject)
Pizzuti Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
3:32 PM
Crinetics Pharmaceuticals (Issuer)
Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
4:31 PM
Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
3:32 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:03 PM
Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
10:01 AM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
How to piss off your liberal friends… and profit from it (Ad)

Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.

To get the full details on the fake “energy crisis” of America, watch this now
06/24/2024
5:07 PM
Crinetics Pharmaceuticals (Subject)
Pizzuti Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
4:08 PM
Crinetics Pharmaceuticals (Issuer)
Hassard James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:24 PM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
3:45 PM
Crinetics Pharmaceuticals (Filer)
Form S-3ASR
06/21/2024
3:31 PM
Crinetics Pharmaceuticals (Subject)
Hassard James (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2024
3:35 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:30 PM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
10:55 AM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
3:35 PM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
12:44 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/22/2024
7:23 AM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
5:29 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2024
3:47 PM
Crinetics Pharmaceuticals (Filer)
Form DEF 14A
04/25/2024
3:48 PM
Crinetics Pharmaceuticals (Filer)
Form DEFA14A
04/25/2024
3:50 PM
Crinetics Pharmaceuticals (Filer)
Form ARS
04/22/2024
4:23 PM
Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
3:30 PM
Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
3:36 PM
Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
4:09 PM
Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:52 PM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
3:17 PM
Crinetics Pharmaceuticals (Subject)
Struthers Richard Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2024
3:30 PM
Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
3:31 PM
Crinetics Pharmaceuticals (Issuer)
Fust Matthew K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
1:34 PM
Crinetics Pharmaceuticals (Subject)
Knight Jeff E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/21/2024
4:20 PM
Crinetics Pharmaceuticals (Subject)
Knight Jeff E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2024
5:31 PM
Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:32 PM
Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:33 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:34 PM
Crinetics Pharmaceuticals (Issuer)
Hassard James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:35 PM
Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
5:36 PM
Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
4:37 PM
Crinetics Pharmaceuticals (Subject)
Fust Matthew K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2024
3:40 PM
Crinetics Pharmaceuticals (Subject)
Pizzuti Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2024
5:31 AM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
3:15 PM
Crinetics Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
03/11/2024
2:34 PM
Crinetics Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G
03/06/2024
7:18 PM
Crinetics Pharmaceuticals (Issuer)
Hassard James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:59 PM
Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
7:00 PM
Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
7:01 PM
Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
7:01 PM
Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
6:57 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:05 PM
Crinetics Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13D/A
03/01/2024
3:41 PM
Crinetics Pharmaceuticals (Filer)
Form S-8 POS
02/28/2024
3:31 PM
Crinetics Pharmaceuticals (Subject)
Krasner Alan Seth (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
5:36 PM
Crinetics Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
02/14/2024
6:54 AM
Crinetics Pharmaceuticals (Subject)
DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G/A
02/09/2024
7:50 AM
Crinetics Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G
01/26/2024
4:50 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
9:28 AM
Crinetics Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
How to piss off your liberal friends… and profit from it (Ad)

Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.

To get the full details on the fake “energy crisis” of America, watch this now
01/12/2024
3:12 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
11:10 AM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
7:03 AM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
3:43 PM
Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:45 PM
Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:44 PM
Crinetics Pharmaceuticals (Subject)
Wilson Marc (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/27/2023
4:20 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
10:47 AM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/22/2023
5:45 PM
Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CRNX) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners